Q32 Bio Inc.

QTTB

Held by 1 specialist biotech fund

Share on X

Fund Holdings

OrbiMed Advisors

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

OrbiMed AdvisorsNEWFeb 17, 2026

Shares: 2,252,987Value: $7.5M

# Signal Note: OrbiMed Initiates $7.5M Position in Q32 Bio OrbiMed's new 2.25M share position in QTTB signals confidence in the company's lead program, QSX-002, a differentiated approach to autoimmune disease with clinical readouts potentially materializing in 2024-2025. For a mega-cap healthcare investor with deep due diligence capabilities, a de novo position at this scale typically reflects conviction around clinical efficacy, competitive positioning, or near-term value inflection.

More QTTB Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

APLS1 fund RNA1 fund BIOA1 fund IRON1 fund ANRO1 fund FOLD1 fund BCAX1 fund ARGX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: